Acusphere Inc., 6.5% Convertible Exchangeable Preferred Stock (ACUSP*)
OTOTC · · CUSIP 00511R862
This security is no longer trading as of 12/16/2009.
The reference information below — security type, terms, ratings and company profile — is retained for research. Current pricing is not available.
Price History•••••
Final Price•••.••
Historical Chart•••••
Free registration unlocks the full price history and chart for ACUSP*, plus the quote, yields and fundamentals for every actively traded security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Details

Coupon Rate
6.50%
Liquidation Preference
$50.00
Call Price
$51.95
Call / Redemption Date
3/6/2009
Maturity Date
None
Distribution Period
Q
Rate Type
Fixed
Annual Distribution
3.25
Distribution Dates
3/1, 6/1, 9/1 & 12/1
Credit Ratings
Moody's NF · S&P NF (9/27/2009)
Conversion
7.2886 @ $6.86
Tax-Advantaged Dividends
Yes

Security Profile

Security's distribution is suspended.
Security Type
Traditional Convertible Preferred Stock »
CUSIP
00511R862
Market Cap
Micro Cap · $34 Million
IPO
2/18/2005 · $50.00/share
Parent Company
Acusphere, Inc. (ACUS)
Business: Acusphere Inc., 6.5% Convertible Exchangeable Preferred Stock, liquidation preference $50 per share, redeemable at the issuer's option on or after 3/6/2009 at $51.95 per share which declines to $50 on 3/1/2015 (see chart on page S-22 of the prospectus) plus accrued and unpaid dividends, with no stated maturity, and with distributions of 6.5% ($3.25) per annum paid quarterly on 3/1, 6/1, 9/1 & 12/1 to holders of record on the date fixed by the board, not more than 60 days or less than 10 days prior to the payment date. The preferred shares are convertible any time at the holder's option into 7.2886 common shares of Acusphere Inc. (Nasdaq: ACUS), an initial conversion price of $6.86 per common share. If the price of the common stock exceeds $10.30 (150% of the conversion price) for 20 of any 30 consecutive trading days, the company may, at their option, force the preferred shares to be converted into common shares at the then prevailing conversion price. If the preferred is converted prior to 3/1/2009 at either the company's or the holder's option, the company will make an additional payment equal to the aggregrate amount of the cumulative dividends to that date. In regards to payment of dividends and upon liquidation, the preferred shares rank equally with other preferreds and senior to the common shares of the company. See the IPO prospectus for further information on the convertible preferred stock and the conversion provisions by clicking on the ‘Link to IPO Prospectus’ provided below.
Notes: Declared an inactive security by the Other OTC on 12/16/2009. ____________ From the 10-Q report filed with the SEC on 11/10/2008 -- In February 2008 and May 2008, the Company’s Board of Directors did not declare the quarterly cash dividend on the preferred stock, payable on March 1, 2008 and June 1, 2008, respectively. On August 30, 2008, the Board of Directors of the Company again elected not to declare a quarterly cash dividend in the amount of $0.8125 per share on the preferred stock that was otherwise payable on September 1, 2008. This is the third quarterly dividend that has not been declared and paid on the preferred stock. Under the terms of the preferred stock, the holders thereof shall be entitled to vote as a separate class to elect two directors if the Company has not paid the equivalent of six or more quarterly dividends, whether or not consecutive. These voting rights will continue until the Company pays the full accrued but unpaid dividends on the preferred stock. The dividend payable on September 1, 2008, which would have totaled $0.4 million in the aggregate, has been included in current liabilities as of September 30, 2008. Currently, there is a balance in current liabilities for total dividends payable as of September 30, 2008 of approximately $0.8 million.

Company Contact

CEO
Sherri C. Oberg
CFO
John F. Thero
Headquarters
500 Arsenal Street, Watertown, MA 02472
Phone
617-648-8800
Fax
617-926-4750
Investor Relations
617-925-3444 · IR@acusphere.com
Email Form
Request Form »
SEC EDGAR Filings
View filings »